Therefore, IL33-producing ILC2 is feasible to accelerate the expansion of pulmonary Treg cells, even to promote their activity in pulmonary epithelial regeneration in the early stage during ARDS. This evidence concerns the gene IL33 and acute respiratory distress syndrome.